MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
1432.25%
Quick Ratio
1432.25%
Cash Ratio
793.52%
Debt to Asset Ratio
7.05%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Short-term investments
Prepaid expenses and other curre...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
44,318
53,487
19,941
18,003
Short-term investments
34,069
31,801
38,060
43,918
Prepaid expenses and other current assets
1,604
2,203
1,936
2,095
Total current assets
79,991
87,491
59,937
64,016
Long-term investments
1,469
0
2,013
3,219
Other assets, long-term
216
-
0
0
Total assets
81,676
87,491
61,950
67,235
Accounts payable
1,967
2,615
3,021
2,226
Accrued compensation
1,095
613
2,418
1,744
Accrued liabilities
1,747
1,767
2,052
2,705
Other current liabilities
776
567
1,229
183
Total current liabilities
5,585
5,562
8,720
-
Other non-current liabilities
170
170
170
-
Total liabilities
5,755
5,732
8,890
6,858
Additional paid-in capital
335,107
332,742
293,953
292,553
Accumulated other comprehensive (loss) gain
-23
-5
57
64
Accumulated deficit
-259,163
-250,978
-240,950
-232,240
Total stockholders' equity
75,921
81,759
53,060
60,377
Total liabilities and stockholders' equity
81,676
87,491
61,950
67,235
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$44,318K
(143.24%↑ Y/Y)
Short-term investments
$34,069K
(-23.78%↓ Y/Y)
Prepaid expenses and
other current assets
$1,604K
(-65.19%↓ Y/Y)
Total current assets
$79,991K
(18.46%↑ Y/Y)
Long-term investments
$1,469K
(-82.30%↓ Y/Y)
Other assets,
long-term
$216K
Total assets
$81,676K
(7.72%↑ Y/Y)
Total liabilities and
stockholders' equity
$81,676K
(7.72%↑ Y/Y)
Total stockholders'
equity
$75,921K
(10.28%↑ Y/Y)
Total liabilities
$5,755K
(-17.59%↓ Y/Y)
Accumulated deficit
-$259,163K
(-16.28%↓ Y/Y)
Accumulated other
comprehensive (loss) gain
-$23K
(-192.00%↓ Y/Y)
Additional paid-in capital
$335,107K
(14.88%↑ Y/Y)
Total current
liabilities
$5,585K
Other non-current
liabilities
$170K
Accounts payable
$1,967K
(-6.91%↓ Y/Y)
Accrued liabilities
$1,747K
(-40.86%↓ Y/Y)
Accrued compensation
$1,095K
(-8.67%↓ Y/Y)
Other current
liabilities
$776K
(8.23%↑ Y/Y)
Buy us a coffee
AN2 Therapeutics, Inc. (ANTX)
AN2 Therapeutics, Inc. (ANTX)